Short Bowel Syndrome (SBS) Market Projected to Surge to $5.7 Billion Globally by 2030, with High CAGR in GLP-2 and Growth Hormone Segments Dublin, March 06, 2024 (GLOBE NEWSWIRE) -- The "Short Bowel Syndrome (SBS) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global Short Bowel...

Short Bowel Syndrome Epidemiology Forecast Highlights Significant Market Trends Through 2032 in Updated Research Publication Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Short Bowel Syndrome - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The recent publication of the...

Short Bowel Syndrome (SBS) Market to 2030: GLP-2 Therapies to Experience Surge in Growth Dublin, Dec. 21, 2023 (GLOBE NEWSWIRE) -- The "Short Bowel Syndrome (SBS) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The Short Bowel Syndrome...